Biomind Labs Inc

As of June 30, 2026, Biomind Labs Inc has 77.57M shares outstanding.

As of June 30, 2026, Biomind Labs Inc maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -43.57, indicating conservative leverage, while an interest coverage ratio of -19.47 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -13,675.38, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 3.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Biomind Labs Inc generated - - in revenue and converted that into -2.06M in net income, yielding earnings per share of -0.03. EBITDA reached -1.95M, while operating income came in at -1.95M.

As of June 30, 2026, Biomind Labs Inc holds 49.67 in cash and equivalents against 1.18M in total debt, resulting in a net debt position of 1.18M. Total book value stands at -2.70M, with working capital of -2.70M providing operational flexibility.

Biomind Labs Inc produced -330,176.37 in operating cash flow over the twelve months ended June 30, 2026.

Biomind Labs Inc's most recent stock split took place on October 30, 2018 with a 1:20 split ratio.